$GMTX 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Gemini Therapeutics is a clinical stage precision medicine company developing novel therapeutic compounds to treat genetically de?ned age-related macular degeneration (AMD). Gemini's lead candidate, GEM103, is a recombinant form of the human complement factor H protein (CFH), and is designed to address both complement hyperactivity and restore retinal health in patients with AMD. GEM103 is currently in a Phase 2a trial in dry AMD patients with a CFH risk variant. The company has generated a rich pipeline including recombinant proteins, gene therapies, and monoclonal antibodies.

Exchange

NASDAQ/NMS (GLOBAL MARKET)

Website

geminitherapeutics.com

$1B

Total Revenue

None

Employees

$211M

Market Capitalization

1.74

Price/Earning ratio

Similar Companies

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Charles River Laboratories Int CRL 21115 3273 9.00 53.28 12.10
Exact Sciences Corp. EXAS 15524 1712 4.63 -17.52 -49.89
PRA Health Sciences Inc PRAH 10739 3333 6.88 50.52 6.40
Syneos Health Inc SYNH 9147 4730 2.78 38.89 4.99
Medpace Holdings Inc MEDP 7055 1028 7.81 40.02 17.02
Exelixis Inc EXEL 6902 1157 3.31 74.14 8.13
Twist Bioscience Corp TWST 5634 127 9.68 -42.81 -106.59
Allakos Inc ALLK 5438 9.89 -27.30 None
Vir Biotechnology Inc VIR 5162 183 7.14 -17.02 -162.74
Sana Biotechnology Inc SANA 3669 4.21 -11.20 None
Recursion Pharmaceuticals Inc RXRX 3242 9 5.07 -26.44 None
Lyell Immunopharma Inc LYEL 3126 8 3.06 -16.15 None
Instil Bio Inc TIL 2312 0 3.63 -28.00 None
Alx Oncology Holdings Inc ALXO 2166 1 5.39 -18.67 -401.23
Verve Therapeutics Inc VERV 2083 5.13 -21.06 None
Allogene Therapeutics Inc ALLO 2062 38 2.19 -8.60 -621.84
Erasca Inc ERAS 2055 -14.41 -16.25 None
Sorrento Therapeutics Inc SRNE 1840 51 11.05 -5.81 -626.43
Cortexyme Inc CRTX 1710 11.90 -19.39 None
Constellation Pharmaceuticals CNST 1564 4.32 -11.18 None
Castle Biosciences Inc CSTL 1554 78 4.09 -66.91 -28.88
Pandion Therapeutics Inc PAND 1501 1069 1.83 -13.34 -10.55
AlloVir Inc ALVR 1480 0 5.06 -12.56 -718.59
Replimune Group Inc REPL 1458 2.91 -16.17 None
Organogenesis Holdings Inc ORGO 1372 433 7.83 18.15 16.17
Rubius Therapeutics Inc RUBY 1330 5.45 -7.67 None
Y-Mabs Therapeutics Inc YMAB 1138 37 4.92 -24.73 -114.04
National Research Corp NRC 1129 140 14.47 31.01 25.62
Caribou Biosciences Inc CRBU 1098 5 -24.96 -21.71 -955.31
Century Therapeutics Inc IPSC 1076 2.42 -15.44 None
Monte Rosa Therapeutics Inc GLUE 1016 2.94 -17.64 None
Cullinan Oncology Inc CGEM 946 19 2.06 -17.35 -284.59
Scholar Rock Holding Corp SRRK 901 16 4.21 -8.33 -687.82
Precigen Inc PGEN 898 101 6.34 -8.13 -107.45
Janux Therapeutics Inc JANX 882 1 2.33 -76.82 -436.67
RAPT Therapeutics Inc RAPT 803 5 4.35 -13.37 7.14
Sutro Biopharma Inc STRO 792 69 2.83 -8.69 -114.69
Imago BioSciences Inc IMGO 776 -9.97 -29.79 None
Design Therapeutics Inc DSGN 765 0 1.91 -39.74 -245.44
MeiraGTx Holdings plc MGTX 723 19 3.80 -12.51 -325.95
Graphite Bio Inc GRPH 718 1.96 -14.58 None
Ideaya Biosciences Inc IDYA 709 36 3.65 -27.21 -84.49
Crinetics Pharmaceuticals Inc CRNX 693 0 3.99 -7.81 -447.78
Talaris Therapeutics Inc TALS 646 2.43 -18.98 None
Precision Biosciences Inc DTIL 547 101 5.78 -10.98 -45.88
Vor Biopharma Inc VOR 546 2.19 -8.34 None
Rallybio Corp RLYB 526 38 -7.86 -12.39 -1.07
Acumen Pharmaceuticals Inc ABOS 525 1 -5.14 -5.41 -550.91
Mirum Pharmaceuticals Inc MIRM 463 11 5.26 -3.04 None
Werewolf Therapeutics Inc HOWL 457 2.47 -2.45 None
Kezar Life Sciences Inc KZR 449 3.26 -9.36 None
Applied Therapeutics Inc APLT 430 14 3.84 -3.77 -19.41
Evelo Biosciences Inc EVLO 401 7.05 -3.79 None
Cue Biopharma Inc CUE 367 5 5.30 -8.50 -802.84
Oyster Point Pharma Inc OYST 360 2.38 -4.51 None
Vera Therapeutics Inc VERA 355 3.91 -6.48 None
Biomea Fusion Inc BMEA 340 1.68 -18.06 None
Sera Prognostics Inc SERA 335 0 -2.33 -14.21 None
Surface Oncology Inc SURF 329 90 2.35 14.71 18.99
Aerovate Therapeutics Inc AVTE 328 -16.22 -22.30 None
Magenta Therapeutics Inc MGTA 325 1.88 -4.68 None
Cabaletta Bio Inc CABA 312 3.20 -8.02 None
Luna Innovations Inc LUNA 299 101 3.70 129.57 2.46
Black Diamond Therapeutics Inc BDTX 278 1.12 -2.65 None
INmune Bio Inc INMB 256 0 7.54 -13.13 None
Pieris Pharmaceuticals Inc PIRS 253 24 6.35 -5.23 -203.73
Compass Therapeutics Inc CMPX 253 8.68 -3.11 None
Candel Therapeutics Inc CADL 247 0 -6.58 -7.10 None
Nextcure Inc NXTC 241 22 0.90 -3.56 -163.57
Sensei Biotherapeutics Inc SNSE 218 1.32 -7.63 None
AquaBounty Technologies Inc AQB 216 0 1.23 -10.59 None
Gemini Therapeutics Inc GMTX 211 1088 0.23 1.74 11.24
Alzamend Neuro Inc ALZN 197 12.61 -32.43 None
Impel NeuroPharma Inc. IMPL 182 3.65 -3.76 None
Elevation Oncology Inc ELEV 179 1.16 -8.02 None
Tscan Therapeutics Inc TCRX 174 6 -2.90 -5.07 -563.14
Hookipa Pharma Inc HOOK 152 20 1.20 -2.48 -304.07
Reneo Pharmaceuticals Inc RPHM 151 0.92 -5.54 None
Unity Biotechnology Inc UBX 124 1 1.93 -1.53 None
IN8bio Inc INAB 112 -5.24 -11.17 None
HCW Biologics Inc HCWB 109 4 -4.95 -16.95 -162.03
Exicure Inc XCUR 104 4 2.81 -2.19 -148.49
Axcella Health Inc AXLA 103 2700 2.21 -1.84 -10.84
Cyclerion Therapeutics Inc CYCN 90 4 1.76 -1.34 None
BioVie Inc BIVI 72 29.90 -0.40 None
Scopus Biopharma Inc SCPS 70 234 -35.55 -3.34 80.93
Eloxx Pharmaceuticals Inc ELOX 70 0 3.17 -1.28 -14.14
Synaptogenix Inc SNPX 65 2.05 -4.31 None
Monopar Therapeutics Inc MNPR 60 2.68 -7.56 None
NanoViricides Inc NNVC 54 1.88 -6.05 None
CohBar Inc CWBR 53 4.84 -3.17 None
Rezolute Inc RZLT 53 3.91 -2.43 None
Acurx Pharmaceuticals Inc ACXP 48 3.14 -6.00 None
Vaccinex Inc VCNX 47 1 3.53 -1.66 -48.71
Cyclo Therapeutics Inc CYTH 39 1 3.77 -1.86 -989.80
TransCode Therapeutics Inc RNAZ 38 -8.08 -10.86 None
Unicycive Therapeutics Inc UNCY 36 113 -8.79 -9.81 7.94
AgeX Therapeutics Inc AGE 35 2 -4.18 -3.68 -522.77
Aridis Pharmaceuticals Inc ARDS 35 0 -3.79 -1.40 -851.00
Cytocom Inc CBLI 30 0 3.88 -12.72 -912.16
Tenax Therapeutics Inc TENX 18 0 27.83 -0.71 -840.64
Geovax Labs Inc GOVX 16 1 1.30 -11.11 -558.09
Kiromic BioPharma Inc KRBP 15 6.91 -1.10 None
Xenetic Biosciences Inc XBIO 14 1 1.73 -1.07 -47.40
Neurotrope Inc NTRP 5 29 0.08 0.76 23.48

Gemini Therapeutics Announces Presentation at 2nd Annual Dry AMD Therapeutic Development Summit

22h ago, source: Benzinga.com

Gemini Therapeutics, Inc. (NASDAQ:GMTX), a clinical stage precision medicine company developing innovative treatments for genetically-defined age-related macular degeneration ...

Gemini Therapeutics Announces Corporate Restructuring to Prioritize Late-Stage Clinical Development of GEM103 for Geographic Atrophy (Form 8-K)

13d ago, source: publicnow.com

Gemini Therapeutics Announces Corporate Restructuring to Prioritize Late-Stage Clinical Development of GEM103 for Geographic Atrophy. CAMBRIDGE, Mass. - October 5, 2021 - Gemini T ...

Gemini Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

5d ago, source: Business Wire

Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically-defined age-rel ...

Gemini Therapeutics Inc (GMTX)

4d ago, source: Investing.com

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and ...

Worldwide Magnetoencephalography Industry to 2028 - Increase in Prevalence of Neurological Disorders is Driving Growth

22h ago, source: Le Lézard

The "Magnetoencephalography Market Size, Share & Trends Analysis Report By Application (Clinical, Research), By End-use (Hospitals, Imaging Centers, Academic & Research Institutes), By Region, And ...

ANANDA Scientific's Liquid Structuretm Cannabidiol (CBD) to Be Clinically Evaluated for Opioid Use Disorder

22h ago, source: Le Lézard

ANANDA Scientific Inc., a biotech pharma company, announced a clinical trial to evaluate Nantheiatm ATL5, an investigational drug using cannabidiol in ANANDA's proprietary Liquid Structuretm delivery ...

How newly public firms responded to questions on diversity

5d ago, source: The Business Journals

The Business Journal emailed 30 companies that went public in the first 9 months of this year to ask for the number of ...

Your Portfolio